Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/19 → 1/1/22 |
Funding
- Merck: $853,000.00
Phase II study of Pembrolizumab Plus Survaxm for glioblastoma at first recurrence
- Ahluwalia, Manmeet (PI)
Project: Research project
Project: Research project
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/19 → 1/1/22 |